CD35 antibody
Quick Overview for CD35 antibody (ABIN4949510)
Target
See all CD35 (CR1) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purification
- Protein G affinity chromatography
-
Immunogen
- Recombinant human protein was used as the immunogen for the CD35 antibody.
-
Isotype
- IgG1 kappa
-
-
-
-
Application Notes
-
Optimal dilution of the CD35 antibody should be determined by the researcher.
1. Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 min
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Immunofluorescence: 1-2 μg/mL,Immunohistochemistry (FFPE): 0.5-1 μg/mL for 30 min at RT (1),Prediluted format : incubate for 30 min at RT (2) -
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the CD35 antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
-
- CD35 (CR1) (Complement Component Receptor 1 (CD35) (CR1))
-
Alternative Name
- CD35
-
Background
- Recognizes a protein of 210-220 kDa, which is identified as the complement receptor 1 (CR1)/CD35. This mAb does not block CR1 activity. It is highly specific to CR1 and shows no cross-reaction with CR2. The primary function of CR1 is to serve as the cellular receptor for C3b and C4b, the most important components of the complement system leading to clearance of foreign macromolecules. The Knops blood group system is a system of antigens located on this protein. Follicular dendritic cells (FDC) are restricted to the B-cell regions of secondary lymphoid follicles. They are CD21+/CD35+/CD1a-. This mAb labels follicular dendritic cells and follicular dendritic cell sarcoma.
-
Pathways
- Complement System, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Endopeptidase Activity
Target
-